241 related articles for article (PubMed ID: 35891540)
1. Overview of Neutralization Assays and International Standard for Detecting SARS-CoV-2 Neutralizing Antibody.
Liu KT; Han YJ; Wu GH; Huang KA; Huang PN
Viruses; 2022 Jul; 14(7):. PubMed ID: 35891540
[TBL] [Abstract][Full Text] [Related]
2. An Assessment of Serological Assays for SARS-CoV-2 as Surrogates for Authentic Virus Neutralization.
Wohlgemuth N; Whitt K; Cherry S; Kirkpatrick Roubidoux E; Lin CY; Allison KJ; Gowen A; Freiden P; Allen EK; ; Gaur AH; Estepp JH; Tang L; Mori T; Hijano DR; Hakim H; McGargill MA; Krammer F; Whitt MA; Wolf J; Thomas PG; Schultz-Cherry S
Microbiol Spectr; 2021 Oct; 9(2):e0105921. PubMed ID: 34704832
[TBL] [Abstract][Full Text] [Related]
3. Evaluating Humoral Immunity against SARS-CoV-2: Validation of a Plaque-Reduction Neutralization Test and a Multilaboratory Comparison of Conventional and Surrogate Neutralization Assays.
Valcourt EJ; Manguiat K; Robinson A; Lin YC; Abe KT; Mubareka S; Shigayeva A; Zhong Z; Girardin RC; DuPuis A; Payne A; McDonough K; Wang Z; Gasser R; Laumaea A; Benlarbi M; Richard J; Prévost J; Anand SP; Dimitrova K; Phillipson C; McGeer A; Gingras AC; Liang C; Petric M; Sekirov I; Morshed M; Finzi A; Drebot M; Wood H
Microbiol Spectr; 2021 Dec; 9(3):e0088621. PubMed ID: 34787495
[TBL] [Abstract][Full Text] [Related]
4. Quantifying Neutralizing Antibodies in Patients with COVID-19 by a Two-Variable Generalized Additive Model.
Liu KT; Gong YN; Huang CG; Huang PN; Yu KY; Lee HC; Lee SC; Chiang HJ; Kung YA; Lin YT; Hsiao MJ; Huang PW; Huang SY; Wu HT; Wu CC; Kuo RL; Chen KF; Hung CT; Oguntuyo KY; Stevens CS; Kowdle S; Chiu HP; Lee B; Chen GW; Shih SR
mSphere; 2022 Feb; 7(1):e0088321. PubMed ID: 35107336
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of Three Quantitative Anti-SARS-CoV-2 Antibody Immunoassays.
Chapuy-Regaud S; Miédougé M; Abravanel F; Da Silva I; Porcheron M; Fillaux J; Diméglio C; Izopet J
Microbiol Spectr; 2021 Dec; 9(3):e0137621. PubMed ID: 34937195
[TBL] [Abstract][Full Text] [Related]
6. Antibody Response against SARS-CoV-2 and Seasonal Coronaviruses in Nonhospitalized COVID-19 Patients.
Ruetalo N; Businger R; Althaus K; Fink S; Ruoff F; Pogoda M; Iftner A; Ganzenmüller T; Hamprecht K; Flehmig B; Bakchoul T; Templin MF; Schindler M
mSphere; 2021 Feb; 6(1):. PubMed ID: 33627511
[TBL] [Abstract][Full Text] [Related]
7. Optimization and evaluation of a live virus SARS-CoV-2 neutralization assay.
Frische A; Brooks PT; Gybel-Brask M; Sækmose SG; Jensen BA; Mikkelsen S; Bruun MT; Boding L; Strandh CP; Jørgensen CS; Krogfelt KA; Fomsgaard A; Lassauniere R
PLoS One; 2022; 17(7):e0272298. PubMed ID: 35901110
[TBL] [Abstract][Full Text] [Related]
8. Inference of SARS-CoV-2 spike-binding neutralizing antibody titers in sera from hospitalized COVID-19 patients by using commercial enzyme and chemiluminescent immunoassays.
Valdivia A; Torres I; Latorre V; Francés-Gómez C; Albert E; Gozalbo-Rovira R; Alcaraz MJ; Buesa J; Rodríguez-Díaz J; Geller R; Navarro D
Eur J Clin Microbiol Infect Dis; 2021 Mar; 40(3):485-494. PubMed ID: 33404891
[TBL] [Abstract][Full Text] [Related]
9. Nanoluciferase-based cell fusion assay for rapid and high-throughput assessment of SARS-CoV-2-neutralizing antibodies in patient samples.
Meyrath M; Szpakowska M; Plesseria JM; Domingues O; Langlet J; Weber B; Krüger R; Ollert M; Chevigné A;
Methods Enzymol; 2022; 675():351-381. PubMed ID: 36220277
[TBL] [Abstract][Full Text] [Related]
10. A cell-based ELISA as surrogate of virus neutralization assay for RBD SARS-CoV-2 specific antibodies.
Pi-Estopiñan F; Pérez MT; Fraga A; Bergado G; Díaz GD; Orosa I; Díaz M; Solozábal JA; Rodríguez LM; Garcia-Rivera D; Macías C; Jerez Y; Casadesús AV; Fernández-Marrero B; Bermúdez E; Plasencia CA; Sánchez B; Hernández T
Vaccine; 2022 Mar; 40(13):1958-1967. PubMed ID: 35193792
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic Value of a SARS-CoV-2 Rapid Test Kit for Detection of Neutralizing Antibodies as a Point-of-Care Surveillance Test.
Chan MMH; Leung KY; Zhang RRQ; Liu D; Fan Y; Khong MKW; Tam AR; Chen H; Yuen KY; Hung IFN; Chan KH
Microbiol Spectr; 2022 Apr; 10(2):e0099321. PubMed ID: 35254121
[TBL] [Abstract][Full Text] [Related]
12. Antibody Responses to BNT162b2 Vaccination in Japan: Monitoring Vaccine Efficacy by Measuring IgG Antibodies against the Receptor-Binding Domain of SARS-CoV-2.
Fujigaki H; Yamamoto Y; Koseki T; Banno S; Ando T; Ito H; Fujita T; Naruse H; Hata T; Moriyama S; Takahashi Y; Suzuki T; Murakami T; Yoshida Y; Yagura Y; Oyamada T; Takemura M; Kondo M; Iwata M; Saito K
Microbiol Spectr; 2022 Feb; 10(1):e0118121. PubMed ID: 35044205
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of SARS-CoV-2 neutralizing antibodies using a vesicular stomatitis virus possessing SARS-CoV-2 spike protein.
Tani H; Kimura M; Tan L; Yoshida Y; Ozawa T; Kishi H; Fukushi S; Saijo M; Sano K; Suzuki T; Kawasuji H; Ueno A; Miyajima Y; Fukui Y; Sakamaki I; Yamamoto Y; Morinaga Y
Virol J; 2021 Jan; 18(1):16. PubMed ID: 33435994
[TBL] [Abstract][Full Text] [Related]
14. Comparison of SARS-CoV-2 spike antibody quantitative titer reporting using the World Health Organization International Standard Units by four commercial assays.
Zhuo R; Charlton C; Plitt S; Thompson LA; Braun S; Day J; Osiowy C; Tipples G; Kanji JN
J Clin Virol; 2022 Nov; 156():105292. PubMed ID: 36108404
[TBL] [Abstract][Full Text] [Related]
15. Development of a Rapid Live SARS-CoV-2 Neutralization Assay Based on a qPCR Readout.
Lichtenegger S; Saiger S; Hardt M; Kulnik S; Wagner GE; Kleinhappl B; Assig K; Zauner A; Ober M; Kimpel J; von Laer D; Zatloukal K; Steinmetz I
J Clin Microbiol; 2022 Jul; 60(7):e0037622. PubMed ID: 35642515
[TBL] [Abstract][Full Text] [Related]
16. Development of ELISA-Based Assay for Detection of SARS-CoV-2 Neutralizing Antibody.
Mishra KP; Singh M; Saraswat D; Singh S
Viral Immunol; 2023 Oct; 36(8):495-502. PubMed ID: 37643285
[TBL] [Abstract][Full Text] [Related]
17. Quantitative SARS-CoV-2 Serology in Children With Multisystem Inflammatory Syndrome (MIS-C).
Rostad CA; Chahroudi A; Mantus G; Lapp SA; Teherani M; Macoy L; Tarquinio KM; Basu RK; Kao C; Linam WM; Zimmerman MG; Shi PY; Menachery VD; Oster ME; Edupuganti S; Anderson EJ; Suthar MS; Wrammert J; Jaggi P
Pediatrics; 2020 Dec; 146(6):. PubMed ID: 32879033
[TBL] [Abstract][Full Text] [Related]
18. Robust validation and performance comparison of immunogenicity assays assessing IgG and neutralizing antibodies to SARS-CoV-2.
Bonhomme ME; Bonhomme CJ; Strelow L; Chaudhari A; Howlett A; Breidenbach C; Hester J; Hammond C; Fuzy M; Harvey L; Swanner V; Ellis J; Greway RR; Pisciella VA; Green T; Kierstead L
PLoS One; 2022; 17(2):e0262922. PubMed ID: 35130298
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of commercially available fully automated and ELISA-based assays for detecting anti-SARS-CoV-2 neutralizing antibodies.
Zedan HT; Yassine HM; Al-Sadeq DW; Liu N; Qotba H; Nicolai E; Pieri M; Bernardini S; Abu-Raddad LJ; Nasrallah GK
Sci Rep; 2022 Nov; 12(1):19020. PubMed ID: 36347859
[TBL] [Abstract][Full Text] [Related]
20. Comparative Investigation of Methods for Analysis of SARS-CoV-2-Spike-Specific Antisera.
Herrlein ML; Hein S; Zahn T; Mhedhbi I; Raupach J; Husria Y; Benz NI; Eisert J; Bender D; Haberger V; Hastert FD; Henss L; Schnierle BS; Stingl JC; Dreher M; Hildt E
Viruses; 2022 Feb; 14(2):. PubMed ID: 35216003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
